37Indexed trials
Market Rank #43 · Evidence Tier A
New Zealand
Neuroscience Intelligence
New Zealand neuroscience intelligence: 37 indexed trials, 7 institutions, research score 25.02.
9Recruiting
7Research institutions
25.0Research score
Evidence profile
24Sponsors
15Disease areas
0Institution works
0Institution citations
Model signals
Opportunity 25 · ML priority 25 · Confidence 100 · Evidence 25.0
These are comparative evidence signals. They do not represent a guarantee of market size or commercial outcome.
Leading disease areas
parkinsons11trials
stroke3trials
epilepsy2trials
multiple_sclerosis2trials
autism2trials
alzheimers2trials
movement_disorders1trials
depression1trials
other_neurology1trials
other_psychiatry1trials
Leading indexed sponsors
Merck Sharp & Dohme LLC7trials
Pfizer5trials
Celgene2trials
AbbVie2trials
Forest Laboratories2trials
Boehringer Ingelheim1trials
Annexon, Inc.1trials
Living Cell Technologies1trials
BRC Operations Pty. Ltd.1trials
Chelsea Therapeutics1trials